Condition
Corneal Abrasion
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 2 (2)
P 3 (1)
Trial Status
Unknown3
Withdrawn1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04159714Not ApplicableTerminatedPrimary
Bandage Contact Lens Application for the Management of Corneal Abrasion
NCT05534217Not ApplicableUnknownPrimary
The Debridement To Treat The Traumatic Corneal Abrasion
NCT04187417Not ApplicableCompletedPrimary
Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions
NCT02483897Phase 3WithdrawnPrimary
Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion
NCT03206723Phase 2UnknownPrimary
Bandage Contact Lenses for Corneal Abrasions
NCT02771392Phase 2UnknownPrimary
Treatment of Corneal Abrasions With Topical Tetracaine
Showing all 6 trials